Cervical Cancer Treatment Guidelines

Initial Diagnostic Workup

The American College of Radiology recommends MRI over CT for tumor extension assessment and should be preferred for pelvic and abdominal imaging in patients with cervical cancer 2, 3
A thoracic CT scan is recommended for metastasis assessment in patients with cervical cancer 2
PET imaging is useful for nodal assessment, particularly in advanced disease, according to the Society of Nuclear Medicine and Molecular Imaging 3
Clinical examination remains fundamental for FIGO staging, as stated by the International Federation of Gynecology and Obstetrics 3

For patients with Stage IA1 cervical cancer without lymphovascular space invasion, the American College of Obstetricians and Gynecologists recommends conization with negative margins or simple hysterectomy based on patient age 2, 1, 3
For patients with Stage IA1 cervical cancer with lymphovascular space invasion, the National Comprehensive Cancer Network recommends adding pelvic lymphadenectomy to the above surgical approach 2, 1, 3
For patients with Stage IB1 and IIA1 cervical cancer, the American College of Radiology recommends radical hysterectomy with pelvic lymphadenectomy, external beam radiation plus brachytherapy, or combined radio-surgery as equally effective treatment options 2, 1, 3
For patients with Stage IB2 and IIA2 cervical cancer, the American Society for Radiation Oncology recommends concurrent chemoradiation with weekly cisplatin 40 mg/m² during external beam radiation therapy, which provides an absolute 5-year survival benefit of 8% for overall survival 1, 3
For patients with Stage IIB-IVA cervical cancer, the National Comprehensive Cancer Network recommends standard treatment with concurrent chemoradiation, including weekly cisplatin 40 mg/m² during external beam radiation therapy, and brachytherapy as an essential component 1, 3
For patients with Stage IVB cervical cancer, the American Society of Clinical Oncology recommends platinum-based combination chemotherapy with bevacizumab as palliative treatment, not curative 4

For patients with locoregional recurrence of cervical cancer, the Society of Gynecologic Oncology recommends salvage chemoradiation with curative intent for radiotherapy-naïve patients, and pelvic exenteration in highly selected cases for previously irradiated patients 2, 4
For patients with distant metastatic recurrence of cervical cancer, the National Comprehensive Cancer Network recommends platinum-based combination chemotherapy as standard treatment 4

The American College of Obstetricians and Gynecologists recommends a surveillance schedule of every 3 months for the first 2 years, every 6 months for years 3-5, and yearly after 5 years, with each visit including clinical and gynecological examination with PAP smear 2, 1
The Society of Gynecologic Oncology recommends annual cervical/vaginal cytology and imaging as indicated 1

The American Society for Radiation Oncology recommends avoiding curative-intent extended-field chemoradiation for patients with paraaortic lymph node involvement and distant metastases 4
The National Comprehensive Cancer Network recommends not exceeding 8 weeks total treatment time for chemoradiation, as this significantly worsens outcomes 3